Sharekhan

Anthem Biosciences Ltd

Fri 1/08/2025,15:58:56 | NSE : Anthem Bio

₹ 738.40-20.75 (-2.73%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 759.00

Previous Close

₹ 759.15

Volume

1138993

Mkt Cap ( Rs. Cr)

₹41469.29

High

₹ 765.80

Low

₹ 732.00

52 Week High

₹ 801.85

52 Week Low

₹ 701.90

Book Value Per Share

₹ 42.92

Dividend Yield

0.00

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Anthem Biosciences Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Anthem Biosciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 12:00PM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 11:50AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 11:40AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 11:30AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 11:20AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 11:11AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 11:00AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 10:50AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 10:40AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 10:30AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 10:20AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 10:10AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 10:00AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 9:50AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 9:40AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 9:30AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 9:20AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 9:10AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 9:00AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 8:50AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 8:40AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 8:30AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 8:20AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 8:10AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 8:00AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 7:50AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 7:40AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 7:30AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 7:20AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 7:10AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences has submitted to BSE the Shareholding Pattern for the Period Ended July 18, 2025

    22 Jul 2025, 7:01AM As of July 2025, 74.69% is owned by Indian Promoters and 25.31% by Public. <p align=justify> Institutional holds 5.10% (Insurance Companies 0.38%) and
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    22 Jul 2025, 7:00AM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences - Updates

    21 Jul 2025, 3:20PM Anthem Biosciences Limited has informed the Exchange regarding 'Appointment of Kfin Technologies Limited as the Registrar and Share Transfer Agent (RT
  • Anthem Biosciences - Updates

    21 Jul 2025, 3:18PM Anthem Biosciences Limited has informed the Exchange regarding 'Appointment of Ms. Divya Prasad as the Compliance Officer of the Company'.
  • Anthem Biosciences - Updates

    21 Jul 2025, 3:16PM Anthem Biosciences Limited has informed the Exchange regarding 'Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations,
  • Anthem Biosciences - Updates

    21 Jul 2025, 3:14PM Anthem Biosciences Limited has informed the Exchange regarding 'Intimation Of Regulation 30(5) Of The Securities And Exchange Board Of India (Listing
  • Anthem Biosciences - Trading Window

    21 Jul 2025, 3:02PM Anthem Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulation
  • Anthem Biosciences - Intimation Under Regulation 30(5) Of The Securities And Exchange Board Of India (Listing Obligation And

    21 Jul 2025, 4:34PM Names of the Key Managerial Personnels of the Company who are authorised to determine the materiality of an event or information and for the purpose o
  • Anthem Biosciences - Announcement Under Regulation 7(1) Of The Securities And Exchange Board Of India (Listing Obligation And

    21 Jul 2025, 4:26PM Intimation of continuation of Kfin Technologies Limited as the Registrar and Share Transfer Agent of Anthem Biosciences Limited
  • Anthem Biosciences - Appointment of Company Secretary and Compliance Officer

    21 Jul 2025, 4:03PM Intimation of continuation of Ms. Divya Prasad as the Compliance Officer of Anthem Biosciences Limited pursuant to Regulation 6(1) of the Securities a
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    21 Jul 2025, 12:50PM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    21 Jul 2025, 12:40PM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences Ltd. debuts with 26.85% premium at Rs 723.10

    21 Jul 2025, 12:30PM Anthem Biosciences Ltd. makes a strong debut on the bourses with scrip got listed at Rs 723.10 on the Bombay Stock Exchange, a 26.85 per cent premium
  • Anthem Biosciences announces launch of initial public offering

    9 Jul 2025, 12:00PM Anthem Biosciences Ltd. has announced public offering of 59561403 shares at a price of Rs 2.00 each for Cash at a Premium of Rs 568.00 per share. The

Key fundamentals

Evaluate the intrinsic value of Anthem Biosciences Ltd stock 

Name March-24 March-23 March-22
Assets 2099.6616 1855.5501 1390.9533
Liabilities 2099.6616 1855.5501 1390.9533
Equity 111.8154 114.0974 8.7763
Gross Profit 504.8861 429.0579 565.4535
Net Profit 374.7807 385.6711 405.9902
Cash From Operating Activities 164.4076 318.9833 333.3458
NPM(%) 26.43 36.48 32.97
Revenue 1417.539 1056.9243 1231.256
Expenses 912.6529 627.8664 665.8025
ROE(%) 15.54 16 16.84

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Anthem Biosciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sharda Cropchem Ltd 1106.90 -2.69 23.78 6845.03 337.37 0.81
Amines and Plasticizers Ltd 227.60 0.61 30.55 4174.37 372.61 0.22
Indogulf Cropsciences Ltd 110.93 1.24 0.00 1784.36 49.78 0.00
Grauer and Weil (India) Ltd 115.60 0.00 33.31 34400.37 346.70 0.43

Company Info

Our Company was originally incorporated as "Anthem Biosciences Private Limited" under the provisions of the Companies Act, 1956, pursuant to a certificate of incorporation dated June 13, 2006, issued by RoC. Subsequently, our Company was converted from a private company to a public company, pursuant to a board resolution dated October 18, 2024 and a resolution passed in the extraordinary general meeting of our Shareholders held on October 18, 2024 following which the name of our Company was changed to "Anthem Biosciences Limited" and a certificate of incorporation consequent upon conversion to public limited company was issued by the RoC on December 10, 2024.Major Events and Milestones:2006- Incorporation of our Company.2007- Commenced operations of our Company at Unit I and set up a custom synthesis plant with a capacity of 6 KL.2008- Commencement of the discovery biology services with a fermentation capacity of 2 KL.2010- Expanded the custom synthesis plant set up at Unit I increasing its capacity from 6 KL to 24 KL.2013- Received the first USFDA audit approval for Unit I.2016- Set up a high potent lab at Unit I - Bommasandra Facility.2017- Our Company, pursuant to an order dated November 30, 2017, amalgamated with Anthem Cellutions (India) Private Limited by way of an acquisition of 100% of its share capital.- Set up a solid phase peptide synthesis GMP lab with a capacity of 6 KL at Unit 1.- Commenced operations of our Company at Unit II and set up an automated GMP compliant custom synthesis plant with a capacity of 128 KL and a fermentation plant with a capacity of 80 KL.- Received the second USFDA audit approval for Unit I.2018- Anthem Cellutions (India) Private Limited amalgamated into our Company.2019- Received the third USFDA approval for Unit I.- Set up a flow chemistry lab at Unit I.2020- Commenced operations in biological facility 2 earmarked for a specific client.2022- Expanded the custom synthesis plant set up at Unit II increasing its capacity to 246 KL.2023- Received the first USFDA audit approval and first therapeutic goods administration audit for Unit II.- Addition of Oligonucleotide lab in Unit I.- Set a cGMP scale continuous flow manufacturing facility for Unit II.2024- Received the: second USFDA audit approval for Unit II; first ANVISA audit approval for Unit I(1); and first ANVISA audit approval for Unit II(1).- Commenced operations of Neoanthem Lifesciences Private Limited, at Unit III designed as a chemistry lab and customer synthesis pilot plant for development, technology transfer and scale-up projects.- Fermentation capacity expanded to 140 KL at Unit II.- Conversion of our Company into a public limited company, under the name "Anthem Biosciences Limited".2025- Received the fourth USFDA approval for Unit I.

Our Company was originally incorporated as "Anthem Biosciences Private Limited" under the provisions of the Companies Act, 1956, pursuant to a certificate of incorporation dated June 13, 2006, issued by RoC. Subsequently, our Company was converted from a private company to a public company, pursuant to a board resolution dated October 18, 2024 and a resolution passed in the extraordinary general meeting of our Shareholders held on October 18, 2024 following which the name of our Company was changed to "Anthem Biosciences Limited" and a certificate of incorporation consequent upon conversion to public limited company was issued by the RoC on December 10, 2024.Major Events and Milestones:2006- Incorporation of our Company.2007- Commenced operations of our Company at Unit I and set up a custom synthesis plant with a capacity of 6 KL.2008- Commencement of the discovery biology services with a fermentation capacity of 2 KL.2010- Expanded the custom synthesis plant set up at Unit I increasing its capacity from 6 KL to 24 KL.2013- Received the first USFDA audit approval for Unit I.2016- Set up a high potent lab at Unit I - Bommasandra Facility.2017- Our Company, pursuant to an order dated November 30, 2017, amalgamated with Anthem Cellutions (India) Private Limited by way of an acquisition of 100% of its share capital.- Set up a solid phase peptide synthesis GMP lab with a capacity of 6 KL at Unit 1.- Commenced operations of our Company at Unit II and set up an automated GMP compliant custom synthesis plant with a capacity of 128 KL and a fermentation plant with a capacity of 80 KL.- Received the second USFDA audit approval for Unit I.2018- Anthem Cellutions (India) Private Limited amalgamated into our Company.2019- Received the third USFDA approval for Unit I.- Set up a flow chemistry lab at Unit I.2020- Commenced operations in biological facility 2 earmarked for a specific client.2022- Expanded the custom synthesis plant set up at Unit II increasing its capacity to 246 KL.2023- Received the first USFDA audit approval and first therapeutic goods administration audit for Unit II.- Addition of Oligonucleotide lab in Unit I.- Set a cGMP scale continuous flow manufacturing facility for Unit II.2024- Received the: second USFDA audit approval for Unit II; first ANVISA audit approval for Unit I(1); and first ANVISA audit approval for Unit II(1).- Commenced operations of Neoanthem Lifesciences Private Limited, at Unit III designed as a chemistry lab and customer synthesis pilot plant for development, technology transfer and scale-up projects.- Fermentation capacity expanded to 140 KL at Unit II.- Conversion of our Company into a public limited company, under the name "Anthem Biosciences Limited".2025- Received the fourth USFDA approval for Unit I.

Read More

Parent Organisation

Anthem Biosciences Ltd.

Founded

13/06/2006

Managing Director

NSE Symbol

ANTHEMEQ

FAQ

The current price of Anthem Biosciences Ltd is ₹ 738.40.

The 52-week high for Anthem Biosciences Ltd is ₹ 765.80 and the 52-week low is ₹ 732.00.

The market capitalization of Anthem Biosciences Ltd is currently ₹ 41469.29. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Anthem Biosciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Anthem Biosciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Anthem Biosciences Ltd shares.

The CEO of Anthem Biosciences Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT